ONCOTRIALS

Current clinical trials

BJMO - volume 6, issue 4, september 2012

Tom Feys MBA, MSc

EORTC 90101 CREATE assesses the antitumour activity and safety of crizotinib across predefined tumour types in patients whose tumours are possibly harbouring specific alterations in ALK and/or MET. (BELG J MED ONCOL 2012;6:129–131)

Read more

Overview of trials running in the Benelux

BJMO - volume 6, issue 3, june 2012

No authors

(BELG J MED ONCOL 2012;6:102–103)

Read more

Overview of trials running in the Benelux

BJMO - volume 6, issue 2, april 2012

No authors

(BELG J MED ONCOL 2012;6:63–69)

Read more

Overview of trials running in the Benelux

BJMO - volume 6, issue 1, february 2012

No authors

(BELG J MED ONCOL 2012;6:26–36)

Read more
X